Log has written
TUESDAY, NOVEMBER 24, 2009
Cancer patients group to contest patent for Roche’s Herceptin
The association is in talks with Lawyers Collective to challenge the patent as it blocks affordable generics
Reply to comment
Dear Colleague in Cancer Control, It is my exceedingly important experience to express that we are facing severe problems with underserved cancer victims who are pausing for as the Global Burden of Cancer. I have no idea and infact I donot have knowledge how to exchange views with you so that I could have expressed beneficial and helpful words to my cancer victims to say a few kind words in regards to health status of cancer victims AFTER GETTING FULL KNOWLEDGE FROM YOU. I am also requesting your honour to help our rural cancer society to work for mankind ceaselessly. If you can guide us further it will be very much helpful for us at this point; at this rural environment where there is nobody to exchange such views. Please spread our mission stories to every one if feasible on your part so that we can see a very peaceful and healthy environment very soon and we would be happy to see the Total Global Health Promotion effectiveness (TGHPE) and Global Cancer Control Programme (GCCP) in true sense and all our people would get back their total dignity to live with a heathy life style. FACT: MORE THAN 94% RURAL CANCER VICTIMS ARE DYING WITHOUT PROPER TREATMENT IN INDIA AND IT IS DUE TO LACK OF MONEY IN MOST CASES. I hope my MISSION is briefly mentioned ELSEWHERE and FEATURE FILM ON RURAL CANCER VICTIMS ARE ON AND YOU MAY EXPECT A COPYOF SUCH FILMS IF YOU NEED AND ALSO STORY OF CANCER VICTIMS IN CONTINUOUS MANNER. I hope you can show us the right path to proceed to help and promote health Globally. VISIT THE Website:http:// www.karmayog.org/ngo/ACS; AND DOCUMENTS AS BELOW. Dr. Debnath.04/01/2008.
SURJYA
  • Please use English to post and reply to comments
  • Please do not use offensive language in the form of racial or ethnic slurs, abuse or personal insults
  • We welcome opinion and debate geared towards finding solutions
  • Please keep comments relevant to the topic
First Name*
Last Name*
Email*
Comments*
Maximum characters allowed-2000
Enter code*
Disclaimer
All the content posted in this category are made by the readers of livemint unless specified otherwise. Livemint is not responsible for the opinions of the readers and the content posted by the readers are not respresentative of the views and opinions of livemint.